Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

Share Price is delayed by 15 minutes
Get Live Data
0.405    -0.01 (-2.41%)
Bid:
0.37
Ask:
0.44
Spread: 0.07 (18.919%)
Market Cap: £3.37m
AST Live PriceLast checked at - London Stock Exchange

Intraday Ascent Resources Share Chart

New Funding

1 Dec 2020 07:00

RNS Number : 0195H
Ascent Resources PLC
01 December 2020
 

1 December 2020

 

Ascent Resources plc

("Ascent" or the "Company")

New Funding

Ascent Resources Plc (LON: AST) the onshore Caribbean, Hispanic American and European focussed energy and natural resources company, is pleased to announce it has secured a new £500,000 loan facility.

New Funding

As announced on 29 October 2020, following a restructuring of the Company's balance sheet and historic obligations, the Company has a current debt balance of £270,020, which is due for maturity in February 2022.

The Company continues to make progress with its Cuban interests, Slovenian asset and claims under the Energy Charter Treaty and UK Slovenia Bilateral Investment Treaty as well as execution of its Special Situations Strategy. To facilitate further progress whilst minimising equity dilution, the Company has signed a loan agreement arranged and managed by Align Research Limited ("Align") to provide, in aggregate, £500,000 through an unsecured loan facility ("Loan Facility" or "Loan") provided equally by Align and RiverFort Global Opportunities PCC Ltd ("Lenders"). The Loan Facility, which is aimed at minimising dilution to shareholders at current prices, provides for the loan to be drawn down in four tranches of £125,000 each on the first business day of January, February, March and April 2021 respectively. The Loan plus a fixed coupon of 8% is repayable in full, at the election of the Lenders, either in cash or in shares at 7.5 pence per share (41.5% premium to the closing bid price on 30 November), on 31 December 2021 (the "Repayment Date"). The only exception to this will be where the Lenders request part or all of the Loan and any coupon to be utilised as consideration in paying for the warrants.

Issue of 7.5p Warrants

As part of the Loan Facility, the Company will issue a total of 6,666,666 warrants to the Lenders (the "Warrants"). The Warrants are exercisable by paying a cash price of 7.5 pence per warrant share (a 41.5% premium to the closing bid price on 30 November), or at the future placing price of any subsequent fundraise during the first 12 months of the Warrants being issued, if lower than 7.5 pence. The Warrants expire three years from the signing of the Loan agreement. In the event the Company announces that it has reached an amicable settlement agreement with the Republic of Slovenia relating to its ECT claim on or before the 31 January 2021 then any undrawn balance of the loan shall be cancelled and on a pro rata basis up to half of any Warrants outstanding may be cancellable by the Company.

Drawdown of Final £100,000 Existing Loan Facility and Exercise of Existing Warrants

 

Additionally, the Company has drawn down the final tranche of £100,000 under the previous loan facility and Align has simultaneously exercised the attached warrants ("Exercised Warrants") which were previously announced on the 6 August 2020. Align is therefore being issued with 4,000,000 Exercised Warrants shares and 320,000 Loan Coupon shares and has voluntarily agreed to a 3 months lock in on these new shares. 

Issue of Equity & TVR

The Company has also agreed to issue 480,000 ordinary shares at 7.5 pence per share ("Supplier Shares") in respect of £36,000 invoice retaining Align for a twelve months research services. These shares are subject to a lock in period of 3 months.

The issue of the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares are being carried out within the Company's existing share authority to issue ordinary shares for cash. Application will be made to the London Stock Exchange for the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares to be admitted to trading on AIM and it is expected that the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares will be admitted to trading on AIM at 8.00 a.m. on or around 7 December 2020.

In accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the Supplier Shares, Exercised Warrants shares, Loan Coupon shares and shares issued during the month under the Company's existing block admission, its issued ordinary share capital will comprise of 95,283,281 ordinary shares. All of the ordinary shares have equal voting rights and none of the ordinary shares are held in Treasury. The total number of voting rights in the Company will therefore be 95,283,281. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company.

Andrew Dennan, the Company's Chief Executive Officer, commented:

"We are pleased to have secured this flexible funding solution as we continue to progress our discussions in Slovenia alongside our growth initiatives across Cuba and multiple broader Special Situations. This is an important time for Ascent and this funding will help facilitate those key workstreams as we look to progress activities right across the portfolio."

 

Enquiries:

Ascent Resources plc

Andrew Dennan

 

Via Vigo Communications

 

WH Ireland, Nominated Adviser & Broker

James Joyce / Chris Savidge

0207 220 1666

Novum Securities, Joint Broker

John Belliss

 

0207 399 9400

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEURSARRUUAOUA
Date   Source Headline
5th Oct 20067:01 amRNSFirst Gas Sales
4th Oct 200611:00 amRNSCorporate Update
28th Sep 20067:02 amRNSInterim Results
12th Sep 20068:00 amRNSBilca Development Update
23rd Aug 20062:00 pmRNSFarm out Agreement and Update
5th Jul 20066:04 pmRNSDirector/PDMR Shareholding
5th Jul 200612:24 pmRNSDirector/PDMR Shareholding
5th Jul 200611:08 amRNSDirector/PDMR Shareholding
4th Jul 200612:05 pmRNSDirector/PDMR Shareholding
3rd Jul 20067:00 amRNSAward of Exploration Permits
28th Jun 20064:16 pmRNSDirectorate Change
9th Jun 200611:16 amRNSJoint Broker Appointment
15th May 200610:00 amRNSNew Non-Executive Director
27th Apr 200611:00 amRNSOperations Update
18th Apr 20067:00 amRNSHolding(s) in Company
12th Apr 200612:11 pmRNSHolding(s) in Company
7th Apr 20065:43 pmRNSDirector/PDMR Shareholding
6th Apr 20066:31 pmRNSDirector/PDMR Shareholding
6th Apr 20068:40 amRNSAcquisition
5th Apr 20065:29 pmRNSHolding(s) in Company
5th Apr 20063:06 pmRNSHolding(s) in Company
24th Mar 20066:03 pmRNSHolding(s) in Company
24th Mar 20067:01 amRNSInterim Results
14th Feb 200611:36 amRNSAcquisition
30th Jan 200612:08 pmRNSNPEL Completion
26th Jan 200610:10 amRNSHolding(s) in Company
19th Jan 20067:00 amRNSAGM Statement
6th Jan 20065:59 pmRNSHolding(s) in Company
30th Dec 200512:05 pmRNSRe. Annual Report
30th Dec 20057:00 amRNSOperational Changes & Options
22nd Dec 20053:40 pmRNSAcquisition
15th Dec 20057:01 amRNSExercise of Warrants
13th Dec 20053:23 pmRNSDirectorate Change
25th Nov 20057:00 amRNSFinal Results
23rd Nov 20058:58 amRNSOperations Update
10th Nov 20051:55 pmRNSDirectorate Change
4th Nov 20057:00 amRNSAcquisition
20th Oct 200512:32 pmRNSAcquisition
26th Sep 20053:26 pmRNSHolding(s) in Company
23rd Sep 20055:34 pmRNSDirector/PDMR Shareholding
23rd Sep 200512:57 pmRNSGrant of options
23rd Sep 20057:01 amRNSSpanish Agreement
16th Sep 20051:32 pmRNSAcquisition in Gabon
30th Aug 20057:00 amRNSMOU in Hungary
17th Aug 20051:06 pmRNSHolding(s) in Company-Replace
17th Aug 200511:16 amRNSHolding(s) in Company
19th Jul 20057:15 amRNSAcquisition
28th Jun 20051:48 pmRNSDirectorate Change
17th Jun 20053:26 pmRNSHolding(s) in Company
2nd Jun 20057:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.